Merck & Co Inc
General ticker "MRK" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $255.9B
Merck & Co Inc does not follow the US Stock Market performance with the rate: -25.4%.
Estimated limits based on current volatility of 1.1%: low 98.01$, high 100.22$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-12-16, amount 0.81$ (Y3.30%)
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [88.48$, 130.03$]
- 2024-12-30 to 2025-12-30 estimated range: [88.45$, 132.49$]
Financial Metrics affecting the MRK estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.50
- Positive: 1.03 < Operating profit margin, % of 4.91
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.34
- Negative: 0 < Inventory ratio change, % of 0.50
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: Investing cash flow per share, $ of -5.40 <= -3.48
- Positive: 2.35 < Operating cash flow per share per price, % of 4.76
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term MRK quotes
Long-term MRK plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $48,704.00MM | $59,283.00MM | $60,115.00MM |
| Operating Expenses | $35,001.00MM | $39,884.00MM | $57,161.00MM |
| Operating Income | $13,703.00MM | $19,399.00MM | $2,954.00MM |
| Non-Operating Income | $176.00MM | $-2,955.00MM | $-1,065.00MM |
| Interest Expense | $806.00MM | $962.00MM | $1,146.00MM |
| R&D Expense | $12,245.00MM | $13,548.00MM | $30,531.00MM |
| Income(Loss) | $13,879.00MM | $16,444.00MM | $1,889.00MM |
| Taxes | $1,521.00MM | $1,925.00MM | $1,524.00MM |
| Profit(Loss) | $12,358.00MM | $14,519.00MM | $365.00MM |
| Stockholders Equity | $38,184.00MM | $45,991.00MM | $37,581.00MM |
| Inventory | $5,953.00MM | $5,911.00MM | $6,358.00MM |
| Assets | $105,694.00MM | $109,160.00MM | $106,675.00MM |
| Operating Cash Flow | $14,109.00MM | $19,095.00MM | $13,006.00MM |
| Capital expenditure | $4,448.00MM | $4,388.00MM | $3,863.00MM |
| Investing Cash Flow | $-16,555.00MM | $-4,960.00MM | $-14,083.00MM |
| Financing Cash Flow | $2,593.00MM | $-9,119.00MM | $-4,810.00MM |
| Earnings Per Share* | $5.16 | $5.73 | $0.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.